107 related articles for article (PubMed ID: 11220675)
1. A VSV-G pseudotyped HIV vector mediates efficient transduction of human pulmonary artery smooth muscle cells.
Li SL; Zhang XY; Ling H; Ikeda J; Shirato K; Hattori T
Microbiol Immunol; 2000; 44(12):1019-25. PubMed ID: 11220675
[TBL] [Abstract][Full Text] [Related]
2. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.
Akkina RK; Walton RM; Chen ML; Li QX; Planelles V; Chen IS
J Virol; 1996 Apr; 70(4):2581-5. PubMed ID: 8642689
[TBL] [Abstract][Full Text] [Related]
3. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
4. The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope.
Agosto LM; Yu JJ; Liszewski MK; Baytop C; Korokhov N; Humeau LM; O'Doherty U
J Virol; 2009 Aug; 83(16):8153-62. PubMed ID: 19493998
[TBL] [Abstract][Full Text] [Related]
5. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1.
Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T
J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575
[TBL] [Abstract][Full Text] [Related]
6. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
7. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
[TBL] [Abstract][Full Text] [Related]
8. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells.
Yu D; Wang W; Yoder A; Spear M; Wu Y
PLoS Pathog; 2009 Oct; 5(10):e1000633. PubMed ID: 19851458
[TBL] [Abstract][Full Text] [Related]
9. Efficient transduction of primary human B lymphocytes and nondividing myeloma B cells with HIV-1-derived lentiviral vectors.
Bovia F; Salmon P; Matthes T; Kvell K; Nguyen TH; Werner-Favre C; Barnet M; Nagy M; Leuba F; Arrighi JF; Piguet V; Trono D; Zubler RH
Blood; 2003 Mar; 101(5):1727-33. PubMed ID: 12406892
[TBL] [Abstract][Full Text] [Related]
10. Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus.
Ohishi M; Shioda T; Sakuragi J
Virology; 2007 May; 362(1):131-8. PubMed ID: 17258261
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
12. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
[TBL] [Abstract][Full Text] [Related]
13. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
14. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
15. Vesicular stomatitis virus G-pseudotyped lentivirus vectors mediate efficient apical transduction of polarized quiescent primary alveolar epithelial cells.
Borok Z; Harboe-Schmidt JE; Brody SL; You Y; Zhou B; Li X; Cannon PM; Kim KJ; Crandall ED; Kasahara N
J Virol; 2001 Dec; 75(23):11747-54. PubMed ID: 11689655
[TBL] [Abstract][Full Text] [Related]
16. Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins.
Zhang XY; La Russa VF; Reiser J
J Virol; 2004 Feb; 78(3):1219-29. PubMed ID: 14722277
[TBL] [Abstract][Full Text] [Related]
17. Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes.
Mühlebach MD; Schmitt I; Steidl S; Stitz J; Schweizer M; Blankenstein T; Cichutek K; Uckert W
J Mol Med (Berl); 2003 Dec; 81(12):801-10. PubMed ID: 14576928
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 replication by vesicular stomatitis virus envelope glycoprotein pseudotyped baculovirus vector-transduced ribozyme in mammalian cells.
Kaneko H; Suzuki H; Abe T; Miyano-Kurosaki N; Takaku H
Biochem Biophys Res Commun; 2006 Nov; 349(4):1220-7. PubMed ID: 16979590
[TBL] [Abstract][Full Text] [Related]
19. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins.
Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP
Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analyses of stability of simple and complex retroviral vectors.
Higashikawa F; Chang L
Virology; 2001 Feb; 280(1):124-31. PubMed ID: 11162826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
